In this gripping episode of Dose of Health, host Abhishek sits down with healthcare strategist Ray Guirgis, Director at Rapha Health Consulting, to dissect the growing crisis within the NHS and explore whether AI-driven innovation can rescue our overwhelmed health system. With experience across both public and private sectors, Ray unpacks the deep inefficiencies plaguing patient journeys, funding structures, and clinical pathways—and reveals how AI solutions like Axonic Health are already revolutionizing care delivery. Are our long GP waits and broken referral systems truly just a funding issue? Or is it time to rethink healthcare entirely?From 7.4 million people stuck on waiting lists to the £100 million spent on translation services, this episode raises bold, uncomfortable questions: Why are patients and clinicians both frustrated? Is private healthcare really the fix we think it is? Can technology deliver faster, fairer, and smarter care for all? Tune in for a high-impact discussion on bureaucracy, digital transformation, and the future of healthcare in the UK. If you found this conversation valuable, please like, share, and follow to support the movement for better healthcare. Want to connect with Ray? Reach out to him on:LinkedIn: https://www.linkedin.com/in/ray-guirguis-7b830130/Email: ray@raphahealth.co.uk.Chapters:0:00 Intro2:55 Patient Journey in the NHS5:36 Issues with GP Appointments11:13 Patient Pathways in the NHS12:28 Communication & Referral problems14:24 Pharmacist role in Primary care16:53 NHS England Shutting down22:22 Comparing NHS with Private care23:56 Advantages of Private Healthcare30:01 Challenges in Private Healthcare33:10 Adoption of technology in Healthcare37:35 Translation cost within NHS41:51 How will Tech and AI solve the Data and Time Issue45:37 Comparing Healthcare & Finance Industry47:47 NHS Bureaucratic Bottlenecks49:40 Fragmentation of data across NHS57:22 Message for decision makers within NHS57:55 Dose of Health58:47 Conclusion and Final thoughtsConnect With Me-Instagram- https://www.instagram.com/abhishekkatiyaryt/TikTok- https://www.tiktok.com/@abhishekkatiyaryt?_t=8pXr93OUjEP&_r=1Patreon- https://www.patreon.com/abhishekkatiyar/membershipBuy Me A Coffee- http://buymeacoffee.com/AbhishekYT

7.4 million people are still waiting for treatment in England. But what if a full hospital visit—registration, consult, blood test, and prescription—could take just 16 minutes? In this eye-opening episode of Dose of Health, host Abhishek Katiyar sits down with Dr. Abhay Chopada, award-winning UK surgeon and health tech founder of Axon Care. Together, they explore how AI and real-time data can revolutionize access, cut waiting times, and finally put patients at the center of care. From fragmented systems to global lessons, this conversation asks the big questions: Is “free” still relevant when care is delayed? And what will it take to truly reform the NHS? Don’t miss this powerful dose of clarity and possibility. Subscribe for more bold conversations that reimagine healthcare.

0:00 Intro

2:37 The Healthcare Crisis: 7.4 million waiting

2:50 The Cost of delayed Healthcare

6:55 The NHS: Challenges and Reforms

17:03 The Role of AI in Healthcare

22:36 Global perspective on Healthcare

24:55 Real Cost of ‘Free’ NHS

26:22 Data Privacy concerns in the UK

27:56 NHS leadership and reform

29:15 NHS Reform through Technology & AI

29:57 Reasons & Inspiration behind Axon Care?

34:20 Benefits of AI integration in Healthcare through Axon care products

45:08 Personal Insights from Dr. Chopada

47:31 Dose of Health

Explore the captivating history and enduring legacy of the National Health Service (NHS) in this episode of Dose of Health. Listen to Abhishek, a specialist pharmacist from the NHS, as he narrates the inspiring journey of healthcare reformers like Aneurin Bevan and Dr. Benjamin Moore. Learn about the profound transformation that created a healthcare system free at the point of use, shaping modern Britain. Discover how the NHS emerged from the ashes of World War II, overcoming challenges and criticisms, to offer equitable healthcare for all citizens. This compelling narrative highlights the fight against diseases, the promise of care without financial burden, and the groundbreaking reforms that have extended life expectancy and improved public health across the UK. Join us for an insightful exploration into the NHS—a symbol of hope, resilience, and a better future for every citizen.

Ever wondered how clinical trials actually work? Curious about the real challenges faced by healthcare professionals during the COVID-19 pandemic? Want to know what it takes to lead pivotal studies in the NHS and transition into the pharmaceutical industry? This video features Nargis Hemat, a research specialist with nearly a decade of experience in healthcare and now an associate director in clinical operations at a leading pharmaceutical company. Nargis shares her journey and insights on clinical research, innovation, and the urgent need for accountability and efficiency within the NHS. Don't miss this eye-opening conversation!

00:00 Intro

01:42 Nargis’s Credentials

04:27 Understanding clinical trials

07:54 Commercial trials and drug development

10:58 Benefits of clinical trials for NHS and patients

14:29 Phases of clinical trials

17:01 Financial gain for NHS and Economy

21:21 Game Changing HIV Study (Flair)

26:08 Challenges of working for the NHS

33:44 Nargis’s MBA journey

36:13 Working within the NHS during COVID

48:19 Transition to pharma

58:14 Advice to young female professionals

Follow us on:Youtube: @doseofhealthshow

Instagram: @abhishekkatiyaryt X: @abhishekkYTtiktok: @abhishekkatiyaryt59:20 Nargis’s ‘Dose of Health’ Moment

Why are UK pharmacies struggling to keep essential medicines in stock? What role do global supply chains, Brexit, and economic policies play in these shortages? How has the war in Ukraine worsened the crisis, and what does this mean for patients who rely on life-saving treatments? In this episode ofDose of Health, we dive into the root causes of the UK’s medicine shortages and explore how pharmacists and patients are navigating this growing crisis.

Join specialist pharmacist Abhishek as he unpacks the complex web of factors contributing to empty pharmacy shelves—from disrupted supply chains in China and India to the impact of Brexit-related trade barriers and NHS drug pricing policies. Through the real-life experiences of pharmacists like Kiran, we reveal the human cost of these shortages and discuss the UK government's response, including emergency measures like Serious Shortage Protocols. If you’re a healthcare professional, patient, or simply concerned about the future of medicine access, this episode is a must-listen. Tune in to understand why this problem won’t go away anytime soon—and what needs to change to fix it.

In this episode of Dose of Health, host Abhishek takes you on a journey through the seismic shifts Brexit has caused within the NHS. From the promises emblazoned on red buses to the harsh realities of medicine shortages, staff shortages, and funding cuts, this story reveals the human cost behind the headlines. Meet the European healthcare workers who felt the ripple effects of the referendum and explore how the NHS grapples with post-Brexit challenges daily. More than just a political analysis, this is a tale of resilience, compassion, and the ongoing fight to protect the lifeline of British healthcare.

Does political correctness help or hurt the NHS? In this thought-provoking episode, Abhishek, a specialist pharmacist, explores how the drive for inclusive language impacts patient care and healthcare professionals alike. Through relatable stories and sharp insights, he questions whether balancing clarity and respect is as straightforward as it seems. Tune in to challenge your perspective and join the conversation about the fine line between intention and impact in our healthcare system.

Ranitidine, once the world’s best-selling drug, is now at the center of one of the biggest pharmaceutical controversies in history. In this episode of Dose of Health, Abhishek, a specialist pharmacist, uncovers how this trusted heartburn medication rose to fame as Zantac, only to be pulled from shelves amid cancer concerns, billion-dollar lawsuits, and allegations of corporate fraud spanning decades. Explore the shocking details of recalls, whistleblower claims, and the fight for justice in this gripping tale of science, deception, and public trust.